Search

Your search keyword '"Braconi, C"' showing total 207 results

Search Constraints

Start Over You searched for: Author "Braconi, C" Remove constraint Author: "Braconi, C"
207 results on '"Braconi, C"'

Search Results

2. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

3. Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice

4. Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer

6. Heterogeneity of Cholangiocarcinoma immune biology

7. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

8. Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Resected Perihilar Cholangiocarcinoma, the ENS-CCA Registry

10. 59TiP Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

14. The impact of gender and immune system determinants on long-term survival in biliary tract cancer

15. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

16. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

19. 80TiP Global phase III study of NUC-1031 plus cisplatin vs gemcitabine plus cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

20. Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of response to DNA damage

22. Liver metastases (LM) from intrahepatic cholangiocarcinoma (iCCA): Outcomes from the European Network for the study of cholangiocarcinoma (ENS-CCA) registry and implications on current American Joint Committee on Cancer (AJCC) staging

23. Identification of a nanostring signature that differentiates early pancreatic cancers according to stromal composition and predicts clinical outcome

24. MicroRNAs: nuovi biomarcatori predittivi di sviluppo di insufficienza renale cronica e ipertensione arteriosa nei pazienti sottoposti a nefrectomia radicale per carcinoma renale

25. MicroRNAs as predictive biomarkers of chronic kidney disease (CKD) in patients (pts) undergoing radical nephrectomy (RN) for kidney cancer

26. Clinical and pre-clinical biomarkers of Regorafenib (REG) efficacy in metastatic colorectal cancer (mCRC) in a phase II trial

28. KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial

31. 731P - Liver metastases (LM) from intrahepatic cholangiocarcinoma (iCCA): Outcomes from the European Network for the study of cholangiocarcinoma (ENS-CCA) registry and implications on current American Joint Committee on Cancer (AJCC) staging

32. PD-003 - Identification of a nanostring signature that differentiates early pancreatic cancers according to stromal composition and predicts clinical outcome

33. Investigating the feasibility of precision medicine in gastrointestinal cancers

35. Prognostic value of the immune-related transcriptome in biliary tract cancers

36. KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial

37. HSP-90 Inhibition is a Promising Therapeutic Strategy in Cholangiocarcinoma and MIR-21 may Serve as a Biomarker of Sensitivity

38. Prognostic role of the LCS-6 KRAS variant in locally advanced rectal cancer : Results of the EXPERT-C trial

41. Retrospective analysis of the role of adjuvant chemotherapy and microRNAs expression in resected cholangiocarcinomas (CCAs)

42. 2188 Prognostic role of the LCS-6 KRAS variant in locally advanced rectal cancer: Results of the EXPERT-C trial

43. P0282 : The long non coding RNA UC.158 modulates growth of Wnt/β;-catenin driven hepatocellular carcinoma (HCC)

47. P64 THE ULTRACONSERVED NON CODING RNA UC.158 IS DOWNSTREAM OF THE WNT/b-CATENIN PATHWAY IN LIVER CANCERS

Catalog

Books, media, physical & digital resources